Principal Financial Group
TRAW icon

Principal Financial Group’s Traws Pharma TRAW Stock Holding History

Principal Financial Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,356
Closed -$1.26M – 2662
2021
Q1 		$1.26M Buy
3,356
+256
+8% +$96.6K ﹤0.01% 1945
2020
Q4 		$541K Buy
+3,100
New +$360K ﹤0.01% 2093

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Principal Financial Group's TRAW Position: Q2 2021 in Review

Principal Financial Group sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 3,356 shares — an estimated $1.26M sold.

Principal Financial Group first reported a position in TRAW in Q4 2020 and held it in 2 quarters. The position peaked at $1.26M in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

  • Principal Financial Group reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
  • Principal Financial Group sold 3,356 Traws Pharma shares in Q2 2021, an estimated $1.26M.
  • Principal Financial Group first reported a position in Traws Pharma in Q4 2020 and held it in 2 quarters.
  • Principal Financial Group's Traws Pharma position peaked at $1.26M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Principal Financial Group's 13F filing for Q2 2021, filed 10 Aug 2021.